Skip to main content
. 2023 Oct 11;3(10):2074–2081. doi: 10.1158/2767-9764.CRC-23-0084

TABLE 4.

Worst treatment-related toxicity logistic regression model of KRAS and cetuximab interaction

Toxicity Variable Comparison OR (95% CI) p-value
Any grade 3+ Toxicity KRAS mutation type Non-variant (RL) vs. Variant 1.17 (0.53–2.60) 0.69
Cetuximab No Cetuximab (RL) vs. Cetuximab 3.42 (1.76–6.67) 0.0003